Clinical Trial Detail

NCT ID NCT02944396
Title Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Paclitaxel + Pemetrexed Disodium + Veliparib

Carboplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium + Veliparib

Age Groups: adult senior

No variant requirements are available.